Articles citing this paper

Steve Aitken is a graduate of the University of East Anglia, UK. He joined SmithKline Beecham, later GlaxoSmithKline, as a research chemist. During this period he completed a postgraduate certificate in Structure Based Drug Design at the University of Nottingham, UK. He briefly worked for Carlton and United Breweries, Australia, before returning to GlaxoSmithKline in psychiatric drug discovery. In late 2003 he emigrated to Christchurch, New Zealand, and is currently studying his Ph.D., on the application of ring closing metathesis to the synthesis of conformationally constrained peptidomimetics, at the University of Canterbury.

Andrew Abell obtained a B.Sc.(Hons1) in Organic Chemistry from the University of Adelaide, and a Ph.D. from the same university, under the supervision of Raph Massy-Westropp. He then spent two years working as a postdoctoral fellow with Alan Battersby at Cambridge University, UK, and in 1988 he took a position at the University of Canterbury, New Zealand. His current research interests include the design, synthesis, and biological properties of peptidomimetics and other molecules that mimic or inhibit important biologically active compounds and processes.